Arcadia Biosciences Inc. said Tuesday it has won approval from the U.S. Food and Drug Administration to sell a byproduct of its genetically modified safflower product as livestock feed.
The approval opens up a potentially large market of cattle and poultry producers for the Davis-based food technology company. It also “improves the overall production economics of GLA safflower oil,” CEO Eric Rey said in a news release.
For years, the company has sold its genetically modified safflower oil as a human nutritional supplement. The company now can market a byproduct of that oil, safflower seed meal, to animal-feed manufacturers.
Arcadia’s safflower seeds are high in omega-6 fatty acid, which some believe have anti-inflammation properties, as well as benefits for skin health, weight management and women’s hormonal balance.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Arcadia wins FDA approval to sell oil byproduct, opening up big new market